Beximco Pharma appoints Dr. Md. Ibraheem Hosein Khan to its Board as Independent Director

– BANGLADESH, Dhaka –  Beximco Pharmaceuticals Limited (LON: BXP), the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, today announced the appointment of Dr. Md. Ibraheem Hosein Khan to its Board as an Independent Director, with effective immediately, replacing Shah Monjurul Hoque who is retiring from the Board.

“I am delighted that Dr. Ibraheem has agreed to join the Board. He brings extensive experience and knowledge, which will be invaluable to the Company as we continue to implement our growth strategy across the domestic and international markets.” said Board Chairman, A S F Rahman.

He added: “On behalf of the Company, I would like to thank Shah Monjurul Hoque for his valuable contribution to the Company and wish him well in the future” 

About Dr. Md. Ibraheem Hosein Khan

Dr. Md. Ibraheem Hosein Khan, before he retired from service in the Bangladesh Government, worked in several different Government departments including the Prime Minister’s Office, Ministry of Land, and Ministry of Cultural Affairs. Dr. Khan has also served as Administrator for the Dhaka South City Corporation.

Dr. Khan holds a Ph.D. from Jahangirnagar University, Dhaka, two master’s degrees, and two bachelor’s degrees from institutions in Bangladesh, Australia, and the United Kingdom.

About Beximco Pharmaceuticals Limited

Beximco Pharma is a leading manufacturer and exporter of medicines based in Bangladesh. Since its inception in 1976, the Company remains committed to the health and wellbeing of people across all the continents by providing access to contemporary medicines. The company’s broad portfolio of generics encompasses diverse delivery systems such as tablets, capsules, liquids, semi-solids, intravenous fluids, metered-dose inhalers, dry powder inhalers, sterile ophthalmic drops, insulins, prefilled syringes, injectables, nebulizer solutions, oral soluble films, etc. The Company also undertakes contract manufacturing for multinational and leading global generic pharmaceutical companies.

Beximco Pharma′s state-of-the-art manufacturing facilities are certified by global regulatory authorities of the USA, Europe, Australia, Canada, GCC, and Latin America, among others and it has a geographic footprint in more than 50 countries. More than 5,500 employees are driving the company towards achieving its aspiration to be among the most admired companies in the world.

For more information:

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.